David Light
36Patents
14h-index
60Co-inventors
84Inventor score
Filing activity: Oct 12, 1983 → Nov 3, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8975302B2 | Polymer particles, nucleic acid polymer particles and methods of making and using the same | Chemistry; Metallurgy | 137 | Active |
| US5256770A | Oxidation resistant thrombomodulin analogs | Human Necessities | 30 | Expired |
| US4757012A | Ascorbic acid intermediates and process enzymes | Chemistry; Metallurgy | 29 | Expired |
| US8574835B2 | Scaffolded nucleic acid polymer particles and methods of making and using | Emerging Cross-Sectional Technologies | 27 | Active |
| US5466668A | Superior thrombomodulin analogs for pharmaceutical use | Chemistry; Metallurgy | 27 | Expired |
| US5827824A | Protease-resistant thrombomodulin analogs | Chemistry; Metallurgy | 23 | Expired |
| US5008193A | Ascorbic acid intermediates and process enzymes | Emerging Cross-Sectional Technologies | 22 | Expired |
| US5004690A | Ascorbic acid intermediates and process enzymes | Chemistry; Metallurgy | 22 | Expired |
| US5863760A | Protease-resistant thrombomodulin analogs | Chemistry; Metallurgy | 20 | Expired |
| US4758514A | Ascorbic acid intermediates and process enzymes | Chemistry; Metallurgy | 20 | Expired |
| US7737145B2 | Diamine derivatives as inhibitors of leukotriene A4 hydrolase | Chemistry; Metallurgy | 19 | Active |
| US9315509B2 | Diamine derivatives as inhibitors of leukotriene A4 hydrolase | Chemistry; Metallurgy | 15 | Active |
| US8569303B2 | Diamine derivatives as inhibitors of leukotriene A4 hydrolase | Chemistry; Metallurgy | 15 | Active |
| US6063763A | Protease-resistant thrombomodulin analogs | Chemistry; Metallurgy | 15 | Expired |
| US4512973A | Method for overcoming trypsin inhibition | Emerging Cross-Sectional Technologies | 9 | Expired |
| US6632791B1 | Thrombomodulin analogs for pharmaceutical use | Human Necessities | 6 | Expired |
| US10066260B2 | Matrix arrays and methods for making same | Chemistry; Metallurgy | 4 | Active |
| US9249461B2 | Scaffolded nucleic acid polymer particles and methods of making and using | Emerging Cross-Sectional Technologies | 3 | Active |
| US10745680B2 | Factor IX fusion proteins and methods of making and using same | Chemistry; Metallurgy | 3 | Active |
| US9797011B2 | Device preparation using condensed nucleic acid particles | Chemistry; Metallurgy | 2 | Active |
| US9534092B2 | Purification systems and methods | Chemistry; Metallurgy | 1 | Active |
| US10221451B2 | Immobilized buffer particles and uses thereof | Physics | 1 | Active |
| US9434805B2 | Polymer particles, nucleic acid polymer particles and methods of making and using the same | Chemistry; Metallurgy | 1 | Active |
| US11267819B2 | Diamine derivatives as inhibitors of leukotriene A4 hydrolase | Chemistry; Metallurgy | 1 | Active |
| US10612017B2 | Scaffolded nucleic acid polymer particles and methods of making and using | Emerging Cross-Sectional Technologies | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.